About Immunodiagnostic Systems Holdings PLC (LON:IDH)
Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology. The automated IVD business consists of 25-OH Vitamin D, specialties and instrument sales. The automated IVD business also consists of the sale or placement of its IDS-iSYS instrument, in addition to selling automated assays and consumables for use in these instruments. The Manual IVD business sells manual assays, radio immunoassays (RIA) and ELISA kits (EIA) to labs. Its assay development is focused in the clinical areas, such as calcium metabolism, bone metabolism, chronic kidney disease, hypertension, fertility and growth. Its subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Nordic A/S and Immunodiagnostic Systems France SAS.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Diagnostic & Testing Substances
- Sub-Industry: N/A
- Symbol: LON:IDH
- CUSIP: N/A
- Web: www.idsplc.com/
- Market Cap: £97.07 million
- Outstanding Shares: 29,415,000
- 50 Day Moving Avg: GBX 327.15
- 200 Day Moving Avg: GBX 306.53
- 52 Week Range: GBX 163.25 - GBX 320
Sales & Book Value:
- Trailing P/E Ratio: 32.35
- P/E Growth: 0.00
- Annual Revenue: £40.04 million
- Price / Sales: 2.42
- Book Value: GBX 1.93 per share
- Price / Book: 1.71
- EBITDA: £5.86 million
- Net Margins: 7.42%
- Return on Equity: 5.43%
- Return on Assets: 4.48%
- Average Volume: 1,666 shs.
Frequently Asked Questions for Immunodiagnostic Systems Holdings PLC (LON:IDH)
What is Immunodiagnostic Systems Holdings PLC's stock symbol?
Immunodiagnostic Systems Holdings PLC trades on the London Stock Exchange (LON) under the ticker symbol "IDH."
How often does Immunodiagnostic Systems Holdings PLC pay dividends? What is the dividend yield for Immunodiagnostic Systems Holdings PLC?
Immunodiagnostic Systems Holdings PLC announced a dividend on Wednesday, June 21st. Investors of record on Thursday, July 20th will be paid a dividend of GBX 4 per share on Friday, August 18th. This represents a yield of 1.37%. The ex-dividend date is Thursday, July 20th. This is an increase from Immunodiagnostic Systems Holdings PLC's previous dividend of $1.20. The official announcement can be viewed at this link. View Immunodiagnostic Systems Holdings PLC's Dividend History.
Who are some of Immunodiagnostic Systems Holdings PLC's key competitors?
Some companies that are related to Immunodiagnostic Systems Holdings PLC include Kadmon Holdings (KDMN), Silence Therapeutics plc (SLN), Organovo Holdings (ONVO), Synthetic Biologics (SYN), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Sinclair Pharma PLC (SPH), Palatin Technologies (PTN), ImmuPharma PLC (IMM), Verona Pharma Plc (VRP), MaxCyte (MXCT), Matinas BioPharma Holdings (MTNB), Summit Therapeutics PLC (SUMM), Arch Therapeutics (ARTH), Ekf Diagnostics Holding PLC (EKF), Synthetic Biologics (SYN), Motif Bio PLC (MTFB) and Nobilis Health Corp (HLTH).
Who are Immunodiagnostic Systems Holdings PLC's key executives?
Immunodiagnostic Systems Holdings PLC's management team includes the folowing people:
- Regis Duval, Chief Executive Officer
- Paul James Martin, Group Finance Director, Director
- Andrew J. Davison, Company Secretary
- Burkhard Wittek Ph.D., Non-Executive Chairman of the Board
- Till Bengt Campe, Non-Executive Director
- Klaus Peter Kaspar, Non-Executive Director
- Peter John Williamson, Non-Executive Director
- Roland Sackers, Senior Non-Executive Independent Director
How do I buy Immunodiagnostic Systems Holdings PLC stock?
Shares of Immunodiagnostic Systems Holdings PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Immunodiagnostic Systems Holdings PLC's stock price today?
MarketBeat Community Rating for Immunodiagnostic Systems Holdings PLC (LON IDH)MarketBeat's community ratings are surveys of what our community members think about Immunodiagnostic Systems Holdings PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Immunodiagnostic Systems Holdings PLC stock can currently be purchased for approximately GBX 330.
Consensus Ratings for Immunodiagnostic Systems Holdings PLC (LON:IDH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Analysts' Ratings History for Immunodiagnostic Systems Holdings PLC (LON:IDH)
(Data available from 10/18/2015 forward)
|6/21/2017||Peel Hunt||Reiterated Rating||Under Review|
Earnings History for Immunodiagnostic Systems Holdings PLC (LON:IDH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Current Year EPS Consensus Estimate: $5.48 EPS
Dividend History by Quarter for Immunodiagnostic Systems Holdings PLC (LON IDH)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Immunodiagnostic Systems Holdings PLC (LON:IDH)Insider Trades by Quarter for Immunodiagnostic Systems Holdings PLC (LON:IDH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/2/2017||Regis Duval||Insider||Buy||2,500||GBX 305||£7,625|
|6/30/2017||Regis Duval||Insider||Buy||9,000||GBX 297||£26,730|
|6/27/2017||Regis Duval||Insider||Buy||5,193||GBX 295||£15,319.35|
|6/21/2017||Paul James Martin||Insider||Buy||2,100||GBX 290||£6,090|
|3/22/2017||Paul James Martin||Insider||Buy||3,000||GBX 277||£8,310|
|1/20/2017||Till Bengt Campe||Insider||Buy||1,800||GBX 249||£4,482|
|1/11/2017||Till Bengt Campe||Insider||Buy||1,500||GBX 245||£3,675|
|7/8/2016||Kaspar,Klaus Peter||Insider||Buy||4,100||GBX 142||£5,822|
|7/1/2016||Kaspar,Klaus Peter||Insider||Buy||5,000||GBX 138||£6,900|
|6/30/2016||Kaspar,Klaus Peter||Insider||Buy||6,000||GBX 137||£8,220|
|6/23/2016||Martin,Paul James||Insider||Buy||10,000||GBX 132||£13,200|
Headline Trends for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Latest Headlines for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Immunodiagnostic Systems Holdings PLC (IDH) Chart for Wednesday, October, 18, 2017